Gamida Cell Ltd.
|
(Name of Issuer)
|
Ordinary shares, par value NIS 0.01 per share
|
(Title of Class of Securities)
|
M47364100
|
(CUSIP Number)
|
December 31, 2018
|
(Date of Event Which Requires Filing of This Statement)
|
☐
|
Rule 13d-1(b)
|
☐
|
Rule 13d-1(c)
|
☒
|
Rule 13d-1(d)
|
CUSIP NO. M47364100
|
13 G
|
Page 2 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Israel Healthcare Ventures 2 L.P.
|
|
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Island of Guernsey
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
7.9%**
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON*
|
|
|
||
PN
|
|
|
|||
|
|
CUSIP NO. M47364100
|
13 G
|
Page 3 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
IHCV2 General Partner Limited
|
|
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Island of Guernsey
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
7.9%**
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON *
|
|
|
||
PN
|
|
|
|||
|
|
CUSIP NO. M47364100
|
13 G
|
Page 4 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Gordon R. L. Snelling
|
|
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Island of Guernsey
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
7.9%**
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON*
|
|
|
||
PN
|
|
|
|||
|
|
CUSIP NO. M47364100
|
13 G
|
Page 5 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Paddy M. Whitford
|
|
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Island of Guernsey
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,915,508
|
|
|
|||
|
|
||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
7.9%**
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON*
|
|
|
||
PN
|
|
|
|||
|
|
(a) |
Name of Issuer:
|
(b)
|
Address of Issuer’s Principal Executive Offices:
|
(d)
|
Title of Class of Securities:
|
Ordinary Shares
|
(e)
|
CUSIP Number:
|
M47364100
|
Item 3 |
Not applicable.
|
Item 4 |
Ownership.
|
Item 5 |
Ownership of Five Percent or Less of a Class.
|
Item 6 |
Ownership of More Than Five Percent on Behalf of Another Person.
|
Item 7 |
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
|
Item 8 |
Identification and Classification of Members of the Group.
|
Item 9 |
Notice of Dissolution of Group.
|
Item 10
|
Certification.
|
ISRAEL HEALTHCARE VENTURES 2 L.P.
|
||
IHCV2 GENERAL PARTNER LIMITED
|
||
GORDON R.L. SNELLING
|
||
PADDY M. WHITFORD
|
||
ISRAEL HEALTHCARE VENTURES 2 L.P.
|
||
By:
|
IHCV2 General Partner Limited
|
By:
|
/s/ Paddy M Whitford
|
|
Name: Paddy M. Whitford
|
||
Title: Director
|
||
For itself and on behalf of IHCV2 General Partner Limited, Gordon R.L. Snelling and Paddy M. Whitford, pursuant to an agreement annexed as Exhibit
1 hereto.
|
ISRAEL HEALTHCARE VENTURES 2 L.P.
|
||
By:
|
IHCV2 GENERAL PARTNER LIMITED
|
|
By:
|
/s/ Paddy M Whitford
|
|
Name:
|
Paddy M. Whitford
|
|
Title:
|
Director
|
IHCV2 GENERAL PARTNER LIMITED
|
||
By:
|
/s/ Paddy M Whitford
|
|
Name:
|
Paddy M. Whitford
|
|
Director
|
||
Gordon R.L. Snelling
|
||
By: /s/ Gordon R.L. Snelling
|
||
Paddy M. Whitford
|
||
By: /s/ Paddy M Whitford
|